Publications by authors named "M Goth"

Claim this Profile
A
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
John Z Metcalfe, Isabelle R Weir, Kimberly K Scarsi, Alberto Mendoza-Ticona, Samuel Pierre, Melanie Goth

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.
Linda J Harrison, Gustavo E Velásquez, Russell R Kempker, Marjorie Z Imperial, Eric Nuermberger, Melanie Goth

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.
Linda Harrison, Gustavo E Velasquez, Russell R Kempker, Marjorie Z Imperial, Eric Nuermberger, Melanie Goth

Res Sq· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD study.
Humberto García Aguilar, Matthias Gorenflo, D Dunbar Ivy, Shahin Moledina, Biagio Castaldi, Melanie Goth

Pulm Circ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity.
Szofia Hajósi-Kalcakosz, Judit Dénes, Miklós Góth

Arch Endocrinol Metab· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis